160 related articles for article (PubMed ID: 31538194)
41. Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.
Valcárcel M; Mendoza L; Hernández JJ; Carrascal T; Salado C; Crende O; Vidal-Vanaclocha F
J Transl Med; 2011 Aug; 9():142. PubMed ID: 21867538
[TBL] [Abstract][Full Text] [Related]
42. Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks.
Palmieri D; Lockman PR; Thomas FC; Hua E; Herring J; Hargrave E; Johnson M; Flores N; Qian Y; Vega-Valle E; Taskar KS; Rudraraju V; Mittapalli RK; Gaasch JA; Bohn KA; Thorsheim HR; Liewehr DJ; Davis S; Reilly JF; Walker R; Bronder JL; Feigenbaum L; Steinberg SM; Camphausen K; Meltzer PS; Richon VM; Smith QR; Steeg PS
Clin Cancer Res; 2009 Oct; 15(19):6148-57. PubMed ID: 19789319
[TBL] [Abstract][Full Text] [Related]
43. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.
Lu X; Mu E; Wei Y; Riethdorf S; Yang Q; Yuan M; Yan J; Hua Y; Tiede BJ; Lu X; Haffty BG; Pantel K; Massagué J; Kang Y
Cancer Cell; 2011 Dec; 20(6):701-14. PubMed ID: 22137794
[TBL] [Abstract][Full Text] [Related]
44. Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11.
Rye PD; Norum L; Olsen DR; Garman-Vik S; Kaul S; Fodstad O
Int J Cancer; 1996 Nov; 68(5):682-7. PubMed ID: 8938153
[TBL] [Abstract][Full Text] [Related]
45. Anti-VCAM-1 SAINT-O-Somes enable endothelial-specific delivery of siRNA and downregulation of inflammatory genes in activated endothelium in vivo.
Kowalski PS; Zwiers PJ; Morselt HW; Kuldo JM; Leus NG; Ruiters MH; Molema G; Kamps JA
J Control Release; 2014 Feb; 176():64-75. PubMed ID: 24389338
[TBL] [Abstract][Full Text] [Related]
46. Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy.
Corroyer-Dulmont A; Valable S; Fantin J; Chatre L; Toutain J; Teulier S; Bazille C; Letissier E; Levallet J; Divoux D; Ibazizène M; Guillouet S; Perrio C; Barré L; Serres S; Sibson NR; Chapon F; Levallet G; Bernaudin M
Sci Rep; 2021 May; 11(1):11239. PubMed ID: 34045576
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics and imaging of 212Pb-TCMC-trastuzumab after intraperitoneal administration in ovarian cancer patients.
Meredith RF; Torgue J; Azure MT; Shen S; Saddekni S; Banaga E; Carlise R; Bunch P; Yoder D; Alvarez R
Cancer Biother Radiopharm; 2014 Feb; 29(1):12-7. PubMed ID: 24229395
[TBL] [Abstract][Full Text] [Related]
48. In vivo magnetic resonance imaging investigating the development of experimental brain metastases due to triple negative breast cancer.
Hamilton AM; Foster PJ
Clin Exp Metastasis; 2017 Feb; 34(2):133-140. PubMed ID: 28108861
[TBL] [Abstract][Full Text] [Related]
49. Preclinical molecular imaging of the translocator protein (TSPO) in a metastases model based on breast cancer xenografts propagated in the murine brain.
Wyatt SK; Manning HC; Bai M; Ehtesham M; Mapara KY; Thompson RC; Bornhop DJ
Curr Mol Med; 2012 May; 12(4):458-66. PubMed ID: 22348613
[TBL] [Abstract][Full Text] [Related]
50. VCAM-1-targeted MRI Improves Detection of the Tumor-brain Interface.
Cheng VWT; de Pennington N; Zakaria R; Larkin JR; Serres S; Sarkar M; Kirkman MA; Bristow C; Croal P; Plaha P; Campo L; Chappell MA; Lord S; Jenkinson MD; Middleton MR; Sibson NR
Clin Cancer Res; 2022 Jun; 28(11):2385-2396. PubMed ID: 35312755
[TBL] [Abstract][Full Text] [Related]
51. Activity of T-DM1 in Her2-positive breast cancer brain metastases.
Bartsch R; Berghoff AS; Vogl U; Rudas M; Bergen E; Dubsky P; Dieckmann K; Pinker K; Bago-Horvath Z; Galid A; Oehler L; Zielinski CC; Gnant M; Steger GG; Preusser M
Clin Exp Metastasis; 2015 Oct; 32(7):729-37. PubMed ID: 26303828
[TBL] [Abstract][Full Text] [Related]
52. Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update.
Arslan C; Dizdar O; Altundag K
Expert Opin Pharmacother; 2014 Aug; 15(12):1643-58. PubMed ID: 25032884
[TBL] [Abstract][Full Text] [Related]
53. Comparison of nine prognostic scores in patients with brain metastases of breast cancer receiving radiotherapy of the brain.
Laakmann E; Riecke K; Goy Y; Kersten JF; Krüll A; Müller V; Petersen C; Witzel I
J Cancer Res Clin Oncol; 2016 Jan; 142(1):325-32. PubMed ID: 26424693
[TBL] [Abstract][Full Text] [Related]
54. Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis.
Gril B; Palmieri D; Qian Y; Smart D; Ileva L; Liewehr DJ; Steinberg SM; Steeg PS
Clin Cancer Res; 2011 Jan; 17(1):142-53. PubMed ID: 21081656
[TBL] [Abstract][Full Text] [Related]
55. Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb.
Boudousq V; Bobyk L; Busson M; Garambois V; Jarlier M; Charalambatou P; Pèlegrin A; Paillas S; Chouin N; Quenet F; Maquaire P; Torgue J; Navarro-Teulon I; Pouget JP
PLoS One; 2013; 8(7):e69613. PubMed ID: 23922757
[TBL] [Abstract][Full Text] [Related]
56. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.
Richert MM; Phadke PA; Matters G; DiGirolamo DJ; Washington S; Demers LM; Bond JS; Manni A; Welch DR
Breast Cancer Res; 2005; 7(5):R819-27. PubMed ID: 16168128
[TBL] [Abstract][Full Text] [Related]
57. Breast cancer subtypes and response to systemic treatment after whole-brain radiotherapy in patients with brain metastases.
Niwińska A; Murawska M; Pogoda K
Cancer; 2010 Sep; 116(18):4238-47. PubMed ID: 20549816
[TBL] [Abstract][Full Text] [Related]
58. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.
Lockman PR; Mittapalli RK; Taskar KS; Rudraraju V; Gril B; Bohn KA; Adkins CE; Roberts A; Thorsheim HR; Gaasch JA; Huang S; Palmieri D; Steeg PS; Smith QR
Clin Cancer Res; 2010 Dec; 16(23):5664-78. PubMed ID: 20829328
[TBL] [Abstract][Full Text] [Related]
59. Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression.
Cao H; Zhang Z; Zhao S; He X; Yu H; Yin Q; Zhang Z; Gu W; Chen L; Li Y
J Control Release; 2015 May; 205():162-71. PubMed ID: 25598420
[TBL] [Abstract][Full Text] [Related]
60. A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis.
Harms JF; Welch DR; Samant RS; Shevde LA; Miele ME; Babu GR; Goldberg SF; Gilman VR; Sosnowski DM; Campo DA; Gay CV; Budgeon LR; Mercer R; Jewell J; Mastro AM; Donahue HJ; Erin N; Debies MT; Meehan WJ; Jones AL; Mbalaviele G; Nickols A; Christensen ND; Melly R; Beck LN; Kent J; Rader RK; Kotyk JJ; Pagel MD; Westlin WF; Griggs DW
Clin Exp Metastasis; 2004; 21(2):119-28. PubMed ID: 15168729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
